Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Head & Neck 2 Genitourinary 2 Breast 2 Tumor-Agnostic 1 Sarcoma 1 Other solid neoplasm 1 Gastrointestinal 1 Dermatologic 1

Conditions

Interventions

Specimen Handling 19 Biopsy 18 Magnetic Resonance Spectroscopy 12 Paclitaxel 9 trastuzumab deruxtecan 4 olaparib 4 X-Rays 4 Taxes 4 nilotinib 3 Radiotherapy 3 Gemcitabine 3 Cisplatin 3 Carboplatin 3 Bevacizumab 3 trametinib 2 talazoparib 2 pembrolizumab 2 omipalisib 2 durvalumab 2 copanlisib 2 aldesleukin 2 Vincristine 2 Topotecan 2 Phantoms, Imaging 2 Leucovorin 2 Immunoglobulin G 2 Fluorouracil 2 Doxorubicin 2 Disulfides 2 Cyclophosphamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Tetrahydrouridine × Tumor-Agnostic × Clear all

NCT01534598 2026-02-10

FdCyd and THU for Advanced Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡